The Effect of High-dose Corticosteroid on Refractory Mycoplasma Pneumoniae Pneumonia in children

A Prospective Multicenter Randomized Controlled Trial for the Effect of High-dose Corticosteroid on Refractory Mycoplasma Pneumoniae Pneumonia in Children - HDCORMPC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1041190001

Enrollment

Registered

2019-04-03

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae Pneumonia Mycoplasma, Corticosteroid

Interventions

High-dose Corticosteroid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Refractory Mycoplasma pneumoniae Pneumonia

Exclusion criteria

Exclusion criteria: Respiratory Failure Required Intubation

Design outcomes

Primary

Measure	Time frame
The Interval between Administration of Corticosteroids and afebrile conditions	—

Secondary

Measure	Time frame
Duration of Hospitalization	—

Contacts

Public ContactYuka Torii

Nagoya University Graduate School of Medicine

torii.yuka.c0@f.mail.nagoya-u.ac.jp+81-52-744-2309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026